Stock Price Quote

BAFNA PHARMACEUTICALS LTD.

NSE : BAFNAPHBSE : 532989ISIN CODE : INE878I01022Industry : Pharmaceuticals & DrugsHouse : Private
BSE102.10-0.75 (-0.73 %)
PREV CLOSE ( ) 102.85
OPEN PRICE ( ) 100.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 479
TODAY'S LOW / HIGH ( )98.05 106.95
52 WK LOW / HIGH ( )98 190.7
NSE102.750.05 (+0.05 %)
PREV CLOSE( ) 102.70
OPEN PRICE ( ) 104.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 102.75 (1428)
VOLUME 368
TODAY'S LOW / HIGH( ) 98.40 104.95
52 WK LOW / HIGH ( )98.1 185.5
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1995
Management Info
Shanmugam Hemalatha - Chairman - Managing Director
Registered Office

Address Bafna Towers,New No 68, Old No.299,Thambu Chetty Street,
Chennai,
Tamil Nadu-600001

Phone 044- 25267517/25270992/42677555

Email info@bafnapharma.com

Website www.bafnapharma.com

Registrars Details
Cameo Corporate Services Ltd
Subramanian Buildings No 1 ,Club House Road,,Chennai
Listing : BSE, NSE, MCX

NEWS

29Jul Bafna Pharmaceuticals informs about vo
Bafna Pharmaceuticals has informed that it attached voting results for t..
28Jul Shareholder Meeting / Postal Ballot-O
Please be informed that the 27th AGM of the Company was held on 28TH JUL..
13Apr Bafna Pharmaceuticals informs about co
Bafna Pharmaceuticals has informed that it enclosing Certificate dated 4..
11Apr Bafna Pharmaceuticals informs about PC
Bafna Pharmaceuticals has informed that it enclosed certificate from Pra..
21Mar Bafna Pharmaceuticals informs about ch
Bafna Pharmaceuticals has informed that Jitendra Kumar Pal ceases to be..

Financials

in Millions
QTR Jun 22 ANNUAL 22
Net Profit13.6251.5099999999999
Gross Profit 13.62 51.5099999999999
Operating Profit 29.6135.94
Net Sales 169.27851.4

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Divi's Lab (BSE)
peergroup  3641.90 (1.71%)
M.Cap ( in Cr)96681.00
Samrat Pharmachem (BSE)
peergroup  1149.10 (3.71%)
M.Cap ( in Cr)355.04
Mercury Laboratories (BSE)
peergroup  630.70 (3.07%)
M.Cap ( in Cr)75.68
Guj. Themis Biosyn (BSE)
peergroup  662.80 (2.68%)
M.Cap ( in Cr)962.96
Smruthi Organics (BSE)
peergroup  225.90 (7.06%)
M.Cap ( in Cr)258.57

Shareholding Pattern

PROMOTERS 90.12%
NON-INSTITUTION 9.88%
MUTUAL FUNDS/UTI 0%
FI/BANKS/INSURANCE 0%
GOVERNMENT 0%
FII 0%

Mf Holdings

Scheme NameHold(%)
No Data Found

About Bafna Pharmaceuticals Ltd.

Bafna Pharmaceuticals Ltd. was incorporated in the year 1995. Its today's share price is 102.1. Its current market capitalisation stands at Rs 241.53 Cr. In the latest quarter, company has reported Gross Sales of Rs. 851.4 Cr and Total Income of Rs.872.42 Cr. The company's management includes Akilapriya Chandrashekar Raju, Shanmugam Hemalatha, R Chitra, Atul Sachdeva, B Kamlesh Kumar, P K Sundaresan.

It is listed on the BSE with a BSE Code of 532989 , NSE with an NSE Symbol of BAFNAPH and ISIN of INE878I01022. It's Registered office is at Bafna Towers,New No 68, Old No.299,Thambu Chetty StreetChennai-600001, Tamil Nadu. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Abhay Jain & Co, R Sathyanarayanan & Co

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)